Comparison of the Effect of Propofol-Remifentanil versus Propofol-Ketamine on Hemodynamic Change and Seizure Duration in Electroconvulsive Therapy

Document Type : Original Article (s)

Authors

1 Assistant Professor, Department of Anesthesiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Professor, Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

3 Student of Medicine, Student Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Nowadays, electroconvulsive therapy (ECT) is an efficient treatment of psychological disorders. The basis of a successful ECT is induction of a seizure with purposeful intensity, quality, and duration. Thus, an appropriate anesthetic agent is required. The current study compared the efficacy of remifentanil versus ketamine add-on therapy to propofol on hemodynamic change and seizure duration in ECT.Methods: The current cross-sectional clinical trial study was conducted on 40 patients under ECT in years 2017-18. Patients were randomly treated with each of the combination therapies as they were randomly treated with one for the first session of ECT, and with the later for the second session. Combinations of anesthesia included treatment with propofol-remifentanil versus propofol-ketamine. Furthermore, all patients received 0.5 mg/kg of succinylcholine and 0.5 mg/kg of propofol. Blood pressure, pulse rate, oxygen saturation, recovery duration, and time of spontaneous respiration following ECT, as well as complications, were recorded and compared.Findings: Two assessed groups were not statistically different regarding systolic (P = 0.180) and diastolic blood pressure (P = 0.920), mean arterial pressure (P = 0.360), oxygen saturation (P > 0.999), and spontaneous respiration in recovery (P = 0.950). Tachycardia incidence (P < 0.001) and duration of recovery stay (P = 0.040) was significantly higher in propofol-ketamine group. Furthermore, nausea and vomiting was more in propofol-ketamine group (8 cases versus 2 cases; P = 0.080). The mean seizure duration was 36.12 ± 7.74 seconds propofol-ketamine and 30.07 ± 5.13 seconds in propofol-remifentanil group with a significant difference (P < 0.001).Conclusion: Based on findings of the current study, combination of propofol-remifentanil was superior to combination of propofol-ketamine regarding seizure duration, hemodynamic stability, and less adverse effects. Due to limited number of studies comparing mentioned remedies, further studies are recommended.

Keywords


  1. Choi P, Pisklakov S, Tilak V, Xiong M. Depression and electroconvulsive therapy: Review of current anesthesia considerations. Open J Depress 2013; 2(3): 32-42.
  2. Firouzian A, Tabassomi F. Is ketamine-propofol mixture (ketofol) an appropriate alternative induction agent for electroconvulsive therapy? Saudi J Anaesth 2013; 7(4): 476-7.
  3. Nishikawa K, Higuchi M, Kawagishi T, Shimodate Y, Yamakage M. Effect of divided supplementation of remifentanil on seizure duration and hemodynamic responses during electroconvulsive therapy under propofol anesthesia. J Anesth 2011; 25(1): 29-33.
  4. Lihua P, Su M, Ke W, Ziemann-Gimmel P. Different regimens of intravenous sedatives or hypnotics for electroconvulsive therapy (ECT) in adult patients with depression. Cochrane Database Syst Rev 2014; (4): CD009763.
  5. Porter R, Booth D, Gray H, Frampton C. Effects of the addition of remifentanil to propofol anesthesia on seizure length and postictal suppression index in electroconvulsive therapy. J ECT 2008; 24(3): 203-7.
  6. Geretsegger C, Nickel M, Judendorfer B, Rochowanski E, Novak E, Aichhorn W. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: A randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. J ECT 2007; 23(4): 239-43.
  7. Wang X, Chen Y, Zhou X, Liu F, Zhang T, Zhang C. Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorder. J ECT 2012; 28(2): 128-32.
  8. Dinwiddie SH, Glick DB, Goldman MB. The effect of propofol-remifentanil anesthesia on selected seizure quality indices in electroconvulsive therapy. Brain Stimul 2012; 5(3): 402-7.
  9. Yalcin S, Aydogan H, Selek S, Kucuk A, Yuce HH, Karababa F, et al. Ketofol in electroconvulsive therapy anesthesia: Two stones for one bird. J Anesth 2012; 26(4): 562-7.
  10. MacPherson R, Marroquin-Harris M, Galvez V, Tor P, Loo C. The effect of adjuvant remifentanil with propofol or thiopentone on seizure quality during electroconvulsive therapy. Anaesth Intensive Care 2016; 44(2): 278-80.
  11. Takekita Y, Suwa T, Sunada N, Kawashima H, Fabbri C, Kato M, et al. Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials. Eur Arch Psychiatry Clin Neurosci 2016; 266(8): 703-17.
  12. Erdogan KG, Yucel A, Colak YZ, Ozgul U, Yologlu S, Karlidag R, et al. Ketofol (mixture of ketamine and propofol) administration in electroconvulsive therapy. Anaesth Intensive Care 2012; 40(2): 305-10.
  13. Nazemroaya B, Shafa A, Khizab M. Comparison of the effect of ketamine and sodium thiopental on blood pressure and heart rate during electroconvulsive therapy in patients admitted to the ward of psychiatry; a double-blind randomized clinical trial. J Isfahan Med Sch 2016; 34(402): 1197-204. [In Persian].
  14. Okamoto N, Nakai T, Sakamoto K, Nagafusa Y, Higuchi T, Nishikawa T. Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: Comparing ketamine and propofol anesthesia. J ECT 2010; 26(3): 223-7.
  15. McGirr A, Berlim MT, Bond DJ, Chan PY, Yatham LN, Lam RW. Adjunctive ketamine in electroconvulsive therapy: Updated systematic review and meta-analysis. Br J Psychiatry 2017; 210(6): 403-7.
  16. Carspecken CW, Borisovskaya A, Lan ST, Heller K, Buchholz J, Ruskin D, et al. Ketamine anesthesia does not improve depression scores in electroconvulsive therapy: A randomized clinical trial. J Neurosurg Anesthesiol 2018; 30(4): 305-13.
  17. Nazemoroaya B, Sayedmoalemi S, Emami SA. Comparison of cardiovascular effects of propofol versus sodium thiopental anesthesia in children undergoing electroconvulsive therapy (ECT). J Isfahan Med Sch 2017; 35(427): 463-9. [In Persian].
  18. Kessler U, Bjorke-Bertheussen J, Soreide E, Hunderi PA, Bache-Mathiesen L, Oedegaard KJ, et al. Remifentanil as an adjunct to anaesthesia for electroconvulsive therapy fails to confer long-term benefits. Br J Anaesth 2018; 121(6): 1282-9.
  19. Stripp TK, Jorgensen MB, Olsen NV. Anaesthesia for electroconvulsive therapy - new tricks for old drugs: A systematic review. Acta Neuropsychiatr 2018; 30(2): 61-9.
  20. Nazemroaya B, Majedi MA, Shetabi H, Salmani S. Comparison of propofol and ketamine combination (ketofol) and propofol and fentanyl combination (fenofol) on quality of sedation and analgesia in the lumpectomy: A randomized clinical Trial. Adv Biomed Res 2018; 7: 134.
  21. Shetabi H, Nazemroaya B, Shafa A, Sarlak S. Comparison of the efficacy of two-drug combination, ketofol and fenofol, on sedation and analgesia in patients under the surgery of port catheter placement and removal. J Isfahan Med Sch 2019; 36(505): 1421-7. [In Persian].
  22. Rozet I, Rozet M, Borisovskaya A. Anesthesia for electroconvulsive therapy: An update. Current Anesthesiology Reports 2018; 8(3): 290-7.
  23. Mayo C, Kaye AD, Conrad E, Baluch A, Frost E. Update on anesthesia considerations for electroconvulsive therapy. Middle East J Anaesthesiol 2010; 20(4): 493-8.